Increased Amyloidogenic Neuronal Injury in HIV‐1–infected APP‐KI Alzheimer's disease mice
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Shaurav Bhattarai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Protein Precursor, HIV-1, Neurons. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Frances and Louie Blumkin and Harriet Singer Research Foundations, NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION A higher incidence of dementia, including Alzheimer's‐like pathology, is observed in aged people living with human immunodeficiency virus‐1 (HIV‐1). However, mechanisms linking HIV‐1 to Alzheimer's disease (AD) pathology remain unclear, due to the lack of animal models that allow for concurrent studies of HIV‐1 and AD. METHODS We created a novel amyloid precursor protein (APP) (Swedish mutation) knock‐in (KI) AD mouse on an immunocompromised NOG background, NOG/APP KM670,671NL /IL‐34 (NAIL). Following CD34+ hematopoietic stem cell (HSC) reconstitution, humanized hNAIL mice develop human microglia‐like cells in the brain and human immune system in the periphery. This allows, for the first time, studies of progressive brain HIV‐1 replication in an AD brain. Four‐month‐old HSC reconstituted mice were infected with the HIV‐1 ADA strain, and evaluated at 8 weeks post infection to study the role of brain HIV‐1 replication on AD‐like pathologies. RESULTS HIV‐1 replication increased amyloid‐beta (Aβ) load in the brain and reduced synaptic and neuronal integrity. Cell type‐specific spatial transcriptomic analysis demonstrated that Aβ and HIV‐1 drive distinct transcriptional patterns, whereas dual pathology amplified AD‐like pathology. Neurons showed the highest transcriptional change, with genes linked to neuroinflammation, protein trafficking, and synaptic dysfunction. DISCUSSION The hNAIL mice enable interrogation of HIV–AD comorbidities, with a future potential for the development of novel therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Förderung
- NINDS NIH HHS
- Frances and Louie Blumkin and Harriet Singer Research Foundations
- NIH HHS
- NIDA NIH HHS
- NIA NIH HHS
- NIMH NIH HHS
- Carol Swarts, MD Emerging Neuroscience Research Laboratory
- the Margaret R. Larson Professorship
Zitieren
APA
Bhattarai, S., Foster, E. G., Kadry, R., Lu, Y., Kumar, M., Qasim, S., Mitra, A., Pathak, H., Poluektova, L. Y., Gorantla, S., Mosley, R. L., Yeapuri, P., & Gendelman, H. E. (2026). Increased Amyloidogenic Neuronal Injury in HIV‐1–infected APP‐KI Alzheimer's disease mice. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71807
Vancouver
Bhattarai S, Foster EG, Kadry R, Lu Y, Kumar M, Qasim S, et al. Increased Amyloidogenic Neuronal Injury in HIV‐1–infected APP‐KI Alzheimer's disease mice. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71807
BibTeX
@article{Bhattarai2026,
author = {Bhattarai, Shaurav and Foster, Emma G and Kadry, Rana and Lu, Yaman and Kumar, Mohit and Qasim, Syed and Mitra, Amrita and Pathak, Harsh and Poluektova, Larisa Y and Gorantla, Santhi and Mosley, R Lee and Yeapuri, Pravin and Gendelman, Howard E},
title = {Increased Amyloidogenic Neuronal Injury in HIV‐1–infected APP‐KI Alzheimer's disease mice},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71807}
}
EUVIMED